Dutch agency advises against insuring Wegovy
Danish drugmaker Novo Nordisk was disappointed that the Dutch government was advised not to cover its hugely popular weight-loss drug Wegovy in the country’s basic insurance. The Netherlands Institute for Health Care said it was unclear whether the health effects of Wegovy were significant enough to offset the costs of the drug.
BELIEBTE BEITRÄGE
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
Mission: Impossible 8 title revealed
November 13, 2024
LIVEÜBERTRAGUNG